Press Releases

SHELTON, CT / ACCESSWIRE / April 30, 2024 / NanoViricides, Inc. (NYSE Amer:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that the Phase I Clinical Trial of NV-387 is completed successfully and data lock is expected soon.

The Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the regulatory agency in India for healthy as well as COVID-19 participants, was closed and completed in April by the Drug... (continue reading...)

LAS VEGAS, NV / ACCESSWIRE / April 30, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"), a leading vertically-integrated multi-state cannabis company, has unveiled its latest innovation with the launch of its new CBD hemp and cannabis derived topical line under the esteemed MEDIZIN brand. These products will be available in store, reach customers through wholesale channels and the hemp derived products will be available online,... (continue reading...)

MARKHAM, ON / ACCESSWIRE / April 30, 2024 / iFabric Corp. ("iFabric" or the "Company") (TSX:IFA.TO)(OTCQX:IFABF), a leading provider of innovative apparel and textile technologies, announces its wholly-owned subsidiary company, Intelligent Fabric Technologies (North America) Inc. ("IFTNA"), has successfully obtained a U.S. Food and Drug Administration ("FDA") Medical Device Registration for its revolutionary apparel products integrating multiple textile... (continue reading...)

ANN ARBOR, MI / ACCESSWIRE / April 30, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, May 9th, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its first quarter ended March 31, 2024. A question-and-answer session will... (continue reading...)

• First-quarter revenue of $12.2 million, compared with $14.8 million in Q1 2023.
• Gross margin of 44%, level with Q1 2023
• Q1 EBITDA adjusted of ($37) thousand compared with $2.8 million in Q1 2023
• SimSports revenue of $2.2 million, up 69% from Q1 2023
• In April, new OEM partner TRYX introduced a line of all-in-one CPU coolers, featuring unique new features including a custom display
• Full-year 2024 outlook maintained - expected revenue in the range of -5% to 5% compared with... (continue reading...)